First months of use of dapagliflozin by doctors in France. DapaUse-DT Study. Well-targeted prescriptions and favorable real-life data

Jun-22

AUTHORS : Serge Halimi, CHU Grenoble Alpes, Université Grenoble Alpes, faculté de médecine de Grenoble, service d’endocrinologie, Grenoble, France / 11, rue Voltaire, 38000 Grenoble, France – Email: mmmshal@gmail.com

JOURNAL : Médecine des Maladies Métaboliques

REFERENCE: In press, corrected proof

DOI : 10.1016/j.mmm.2022.06.001

First months of use of dapagliflozin by doctors in France. DapaUse-DT Study. Well-targeted prescriptions and favorable real-life data

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease